Biomedical Engineering Reference
In-Depth Information
References
1. Abuchowski A, van Es T, Palczuk NC, Davis FF (1977) Alteration of immunological
properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol
Chem 252:3578-3581
2. Abuchowski A, McCoy JR, Palczuk NC, van Es T, Davis FF (1977) Effect of covalent
attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver
catalase. J Biol Chem 252:3582-3586
3. Roberts MJ, Bentley MD, Harris JM (2002) Chemistry for peptide and protein PEGylation.
Adv Drug Deliv Rev 54:459-476
4. Basu A, Yang K, Wang M, Liu S, Chintala R, Palm T, Zhao H, Peng P, Wu D, Zhang Z, Hua J,
Hsieh MC, Zhou J, Petti G, Li X, Janjua A, Mendez M, Liu J, Longley C, Zhang Z, Mehlig M,
Borowski V, Viswanathan M, Filpula D (2006) Structure-function engineering of interferon-
beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic
properties by site-selective mono-PEGylation. Bioconjug Chem 17:618-630
5. Balan S, Choi JW, Godwin A, Teo I, Laborde CM, Heidelberger S, Zloh M, Shaunak S,
Brocchini S (2007) Site-specific PEGylation of protein disulfide bonds using a three-carbon
bridge. Bioconjug Chem 18:61-76
6. Brocchini S, Godwin A, Balan S, Choi JW, Zloh M, Shaunak S (2008) Disulfide bridge based
PEGylation of proteins. Adv Drug Deliv Rev 60:3-12
7. Wong SS (1991) Chemistry of Protein Conjugation and Cross- linking. CRC Press, Boston
8. Hu J, Sebald W (2011) N-terminal specificity of PEGylation of human bone morphogenetic
protein-2 at acidic pH. Int J Pharm 413:140-146
9. Lee H, Jang IH, Ryu SH, Park TG (2003) N-terminal site-specific mono-PEGylation of
epidermal growth factor. Pharm Res 20:818-825
10. Renwick W, Pettengell R, Green M (2009) Use of filgrastim and pegfilgrastim to support
delivery of chemotherapy: twenty years of clinical experience. BioDrugs 23:175-186
11. Sato H (2002) Enzymatic procedure for site-specific pegylation of proteins. Adv Drug Deliv
Rev 54:487-504
12. Lorand L, Parameswaran KN, Stenberg P, Tong YS, Velasco PT, Jonsson NA, Mikiver L,
Moses P (1979) Specificity of guinea pig liver transglutaminase for amine substrates. Bio-
chemistry 18:1756-1765
13. Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature's biological glues.
Biochem J 368:377-396
14. Fontana A, Spolaore B, Mero A, Veronese FM (2008) Site-specific modification and
PEGylation of pharmaceutical proteins mediated by transglutaminase. Adv Drug Deliv Rev
60:13-28
15. Otsuka H, Nagasaki Y, Kataoka K (2003) PEGylated nanoparticles for biological and pharma-
ceutical applications. Adv Drug Deliv Rev 55:403-419
16. Nagasaki Y, Iijima M, Kato M, Kataoka K (1995) Primary amino-terminal heterobifunctional
poly(ethylene oxide). Facile synthesis of poly(ethylene oxide) with a primary amino group at
one end and a hydroxyl group at the other end. Bioconjug Chem 6:702-704
17. Nagasaki Y, Kutsuna T, Iijima M, Kato M, Kataoka K, Kitano S, Kadoma Y (1995) Formyl-
ended heterobifunctional poly(ethylene oxide): synthesis of poly(ethylene oxide) with a
formyl group at one end and a hydroxyl group at the other end. Bioconjug Chem 6:231-233
18. Akiyama Y, Nagasaki Y, Kataoka K (2004) Synthesis of heterotelechelic poly(ethylene
glycol) derivatives having alpha-benzaldehyde and omega-pyridyl disulfide groups by ring
opening polymerization of ethylene oxide using 4-(diethoxymethyl)benzyl alkoxide as a novel
initiator. Bioconjug Chem 15:424-427
19. Akiyama Y, Otsuka H, Nagasaki Y, Kato M, Kataoka K (2000) Selective synthesis of
heterobifunctional poly(ethylene glycol) derivatives containing both mercapto and acetal
terminals. Bioconjug Chem 11:947-950
